By Colin Kellaher
Merck & Co. plans to invest $895 million to expand its animal-health operations in De Soto, Kan.
Merck on Thursday said the move includes an $860 million investment in its existing biologics manufacturing facility, along with a $35 million investment in its research-and-development laboratories.
The Rahway, N.J., drug maker said the 200,000-square-foot manufacturing facility project will expand filling and freeze dryer capacity for large molecule vaccines and biologic products for its Merck Animal Health unit, which accounted for roughly 10% of the company's first-quarter sales of more than $15.5 billion.
Merck said site preparation and facility design will start immediately, creating 2,500 construction jobs, with commercial manufacturing slated to begin in 2030, creating more than 200 full-time roles.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
May 08, 2025 09:17 ET (13:17 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.